217 related articles for article (PubMed ID: 24599802)
1. Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
Limmer S; Hahn J; Schmidt R; Wachholz K; Zengerle A; Lechner K; Eibl H; Issels RD; Hossann M; Lindner LH
Pharm Res; 2014 Sep; 31(9):2276-86. PubMed ID: 24599802
[TBL] [Abstract][Full Text] [Related]
2. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
3. DPPG
van Valenberg FJP; Brummelhuis ISG; Lindner LH; Kuhnle F; Wedmann B; Schweizer P; Hossann M; Witjes JA; Oosterwijk E
Int J Nanomedicine; 2021; 16():75-88. PubMed ID: 33447028
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes.
Rysin A; Paal M; Lokerse WJM; Wedmann B; Hossann M; Vogeser M; Winter G; Lindner LH
Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183698. PubMed ID: 34283999
[TBL] [Abstract][Full Text] [Related]
5. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
6. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study.
Lokerse WJM; Lazarian A; Kleinhempel A; Petrini M; Schwarz P; Hossann M; Holdt LM; Mailänder V; Lindner LH
J Control Release; 2021 May; 333():1-15. PubMed ID: 33741385
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific delivery of gemcitabine with activatable liposomes.
Tucci ST; Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Foiret J; Hubbard NE; Borowsky AD; Baikoghli M; Cheng RH; Ferrara KW
J Control Release; 2019 Sep; 309():277-288. PubMed ID: 31301340
[TBL] [Abstract][Full Text] [Related]
9. DPPG
Brummelhuis ISG; Simons M; Lindner LH; Kort S; de Jong S; Hossann M; Witjes JA; Oosterwijk E
Int J Hyperthermia; 2021; 38(1):1415-1424. PubMed ID: 34581259
[TBL] [Abstract][Full Text] [Related]
10. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of 2',2'difluorodeoxycytidine (Gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo.
Van Bree C; Beumer C; Rodermond HM; Haveman J; Bakker PJ
Int J Hyperthermia; 1999; 15(6):549-56. PubMed ID: 10598951
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
[TBL] [Abstract][Full Text] [Related]
13. Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or Excipients.
Rysin A; Lokerse WJM; Paal M; Habler K; Wedmann B; Hossann M; Winter G; Lindner LH
J Pharm Sci; 2023 Jul; 112(7):1947-1956. PubMed ID: 37030437
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma.
Zimmermann K; Hossann M; Hirschberger J; Troedson K; Peller M; Schneider M; Brühschwein A; Meyer-Lindenberg A; Wess G; Wergin M; Dörfelt R; Knösel T; Schwaiger M; Baumgartner C; Brandl J; Schwamberger S; Lindner LH
Int J Hyperthermia; 2017 Mar; 33(2):178-190. PubMed ID: 27592502
[TBL] [Abstract][Full Text] [Related]
15. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.
Moog R; Burger AM; Brandl M; Schüler J; Schubert R; Unger C; Fiebig HH; Massing U
Cancer Chemother Pharmacol; 2002 May; 49(5):356-66. PubMed ID: 11976829
[TBL] [Abstract][Full Text] [Related]
16. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
Gamblin TC; Egorin MJ; Zuhowski EG; Lagattuta TF; Herscher LL; Russo A; Libutti SK; Alexander HR; Dedrick RL; Bartlett DL
Cancer Chemother Pharmacol; 2008 Sep; 62(4):647-53. PubMed ID: 18040687
[TBL] [Abstract][Full Text] [Related]
19. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.
Beumer JH; Eiseman JL; Parise RA; Joseph E; Covey JM; Egorin MJ
Clin Cancer Res; 2008 Jun; 14(11):3529-35. PubMed ID: 18519786
[TBL] [Abstract][Full Text] [Related]
20. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z
J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
